Cargando…
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies
Cholangiocarcinoma is a very heterogeneous and rare group of neoplasms originating from the perihilar, intra-, or extrahepatic bile duct epithelium. It represents only 3% of gastrointestinal cancers, although their incidence is increasing as its mortality increases. Surgical resection is the only po...
Autor principal: | Cidon, E. Una |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869598/ https://www.ncbi.nlm.nih.gov/pubmed/27199577 http://dx.doi.org/10.4137/CMO.S32821 |
Ejemplares similares
-
New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future
por: Cidon, Esther Una
Publicado: (2017) -
Systemic treatment of hepatocellular carcinoma: Past, present and future
por: Cidon, Esther Una
Publicado: (2017) -
The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients
por: Parsons, Matthew, et al.
Publicado: (2022) -
The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
por: Cremen, Sinead, et al.
Publicado: (2022) -
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?
por: Cidon, E. Una, et al.
Publicado: (2016)